191 related articles for article (PubMed ID: 9656829)
1. [Enzyme substitution in Gauscher disease].
Steensberg J; Nielsen KG; Brandt NJ
Ugeskr Laeger; 1998 Jun; 160(26):3900-3. PubMed ID: 9656829
[TBL] [Abstract][Full Text] [Related]
2. [Gaucher disease type 1--therapeutic results of enzyme substitution].
Steensberg J; Nielsen KG; Brandt NJ
Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
[TBL] [Abstract][Full Text] [Related]
3. Imiglucerase treatment in Gaucher's disease.
Shah U; Nadeem N; Husen Y; Fadoo Z
J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
[TBL] [Abstract][Full Text] [Related]
4. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
[TBL] [Abstract][Full Text] [Related]
5. Alglucerase. A review of its therapeutic use in Gaucher's disease.
Whittington R; Goa KL
Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement.
Lebel E; Elstein D; Hain D; Hadas-Halpern I; Zimran A; Itzchaki M
Isr Med Assoc J; 2003 Aug; 5(8):595-6. PubMed ID: 12929302
[No Abstract] [Full Text] [Related]
8. Alglucerase for Gaucher's disease.
Med Lett Drugs Ther; 1991 Aug; 33(851):82. PubMed ID: 1865852
[No Abstract] [Full Text] [Related]
9. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
Pérez-Calvo JI; Giraldo P; Giralt M
Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
Banjar H
Ann Trop Paediatr; 1998 Mar; 18(1):55-9. PubMed ID: 9692003
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].
Hollak CE; van Oers MH; Maaswinkel P; Aerts JM; Goudsmit R
Ned Tijdschr Geneeskd; 1996 May; 140(19):1011-3. PubMed ID: 8684492
[No Abstract] [Full Text] [Related]
12. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
[TBL] [Abstract][Full Text] [Related]
13. [Gaucher's disease and enzyme replacement therapy].
Cornu F
Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
[TBL] [Abstract][Full Text] [Related]
14. Should repeated partial splenectomy be attempted in patients with hematological diseases? Technical pitfalls and causes of failure in Gaucher's disease.
Freud E; Cohen IJ; Neuman M; Mor C; Zer M
J Pediatr Surg; 1997 Sep; 32(9):1272-6. PubMed ID: 9314241
[TBL] [Abstract][Full Text] [Related]
15. Gaucher's disease: a review.
Morales LE
Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
[TBL] [Abstract][Full Text] [Related]
16. Taliglucerase alfa for the treatment of Gaucher's disease.
Haddley K
Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
[TBL] [Abstract][Full Text] [Related]
17. Hematologic response in type I Gaucher's disease after enzyme replacement therapy.
Parco S; Bruno G; Durighello M; Giorgini R; Simeone R; Bembi B
Haematologica; 1999 Apr; 84(4):376-7. PubMed ID: 10190956
[No Abstract] [Full Text] [Related]
18. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
Cleary JE; Burke WM; Baxi LV
Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement therapy for Gaucher's disease.
Beutler E
Baillieres Clin Haematol; 1997 Dec; 10(4):751-63. PubMed ID: 9497862
[TBL] [Abstract][Full Text] [Related]
20. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months].
Versteegh C; Avni F; Cuvelier P; Ferster A
Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
